Home » Stocks » OLK

Olink Holding AB (publ) (OLK)

Stock Price: $31.39 USD -0.61 (-1.91%)
Updated Jun 17, 2021 12:41 PM EDT - Market open
Market Cap 3.81B
Revenue (ttm) 59.70M
Net Income (ttm) n/a
Shares Out 119.01M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 17
Last Price $31.39
Previous Close $32.00
Change ($) -0.61
Change (%) -1.91%
Day's Open 32.00
Day's Range 31.00 - 33.09
Day's Volume 69,136
52-Week Range 25.55 - 42.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

UPPSALA, Sweden, June 15, 2021 (GLOBE NEWSWIRE) --  Scallop-logo-470-pxOlink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the SCALLOP consortium (Systematic and Combined AnaLysis of Ol...

2 days ago - GlobeNewsWire

UPPSALA, Sweden, June 02, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink® Signature Q100, to allow more researchers access to Olink...

2 weeks ago - GlobeNewsWire

UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Confere...

3 weeks ago - GlobeNewsWire

UPPSALA, Sweden, May 20, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its financial results for the first quarter of 2021.

4 weeks ago - GlobeNewsWire

UPPSALA, Sweden, April 29, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, today announced that it will release financial results for the first quarter of...

1 month ago - GlobeNewsWire

Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its...

2 months ago - GlobeNewswire

Olink Holding, which provides a platform of proteome analysis products for biomedical research, filed on Wednesday with the SEC to raise up to $100 million in a US initial public offering.

3 months ago - NASDAQ

Olink Holding AB (publ) has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC

About OLK

Our purpose is to enable and accelerate the field of proteomics by providing a platform of products and services that are deployed across major biopharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. We support 30 of the world’s largest 40 biopharmaceutical companies by 2019 revenue, including all of the largest 19, and many leading academic institutions. Our current offering is based on our pr... [Read more...]

Industry
Diagnostics & Research
IPO Date
Mar 25, 2021
CEO
Jon Heimer
Employees
214
Stock Exchange
NASDAQ
Ticker Symbol
OLK
Full Company Profile

Financial Performance

In 2020, Olink Holding's revenue was $54.07 million, an increase of 29.68% compared to the previous year's $41.69 million. Losses were -$6.78 million, -62.08% less than in 2019.

Financial Statements